On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Michael N. Hall was born (1953) in Puerto Rico and grew up in South America (Venezuela and Peru). He received his Ph.D. from Harvard University and was a postdoctoral fellow at the Pasteur Institute (Paris, France) and the University of California, San Francisco. He joined the Biozentrum of the University of Basel (Switzerland) in 1987 where he is currently Professor and former Chair of Biochemistry.
Hall has won many prestigious prizes for his pioneering research such the Louis-Jeantet prize (2009) and Albert Lasker award (2017).
Hall is a leader in the fields of TOR signalling and cell growth control. In 1991, Hall and colleagues discovered TOR (Target of Rapamycin) and subsequently elucidated its role as a central controller of cell growth and metabolism. TOR plays a key role in development and ageing, and is implicated in various disorders including cancer, cardiovascular disease, diabetes, and obesity.
